Oakwood Capital Managementca Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Oakwood Capital Managementca reduced its stake in Stryker Corporation by 0.29% during the most recent quarter end. The investment management company now holds a total of 43,335 shares of Stryker Corporation which is valued at $4,976,158 after selling 125 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Stryker Corporation makes up approximately 1.25% of Oakwood Capital Managementca’s portfolio.

Other Hedge Funds, Including , Aviance Capital Management added SYK to its portfolio by purchasing 11,770 company shares during the most recent quarter which is valued at $1,351,549. Stryker Corporation makes up approx 0.04% of Aviance Capital Management’s portfolio.Roffman Miller Associates Inc Pa boosted its stake in SYK in the latest quarter, The investment management firm added 615 additional shares and now holds a total of 128,187 shares of Stryker Corporation which is valued at $15,684,961. Stryker Corporation makes up approx 2.50% of Roffman Miller Associates Inc Pa’s portfolio.Independent Portfolio Consultants reduced its stake in SYK by selling 205 shares or 45.05% in the most recent quarter. The Hedge Fund company now holds 250 shares of SYK which is valued at $30,405. Stryker Corporation makes up approx 0.01% of Independent Portfolio Consultants’s portfolio. Bkd Wealth Advisors added SYK to its portfolio by purchasing 2,740 company shares during the most recent quarter which is valued at $335,677. Stryker Corporation makes up approx 0.05% of Bkd Wealth Advisors’s portfolio.

Stryker Corporation opened for trading at $114.97 and hit $116.62 on the upside on Friday, eventually ending the session at $116.28, with a gain of 1.15% or 1.32 points. The heightened volatility saw the trading volume jump to 14,53,717 shares. Company has a market cap of $43,524 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.